Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptomsMichael J. Peluso, Timothy J. Henrich, Saki Takahashi et al.|Cell Reports|2021Cited by 266
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assayMichael J. Peluso, Bryan Greenhouse, Saki Takahashi et al.|Science Advances|2021Cited by 150
Engineering luminescent biosensors for point-of-care SARS-CoV-2 antibody detectionSusanna K. Elledge, James A. Wells, Xin Zhou et al.|Nature Biotechnology|2021Cited by 142
Integration of therapeutic cargo into the human genome with programmable type V-K CASTJason Liu, Brian C. Thomas, Daniela S. Aliaga Goltsman et al.|Nature Communications|2025Cited by 15